BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 20047039)

  • 1. HSV as a vector in vaccine development and gene therapy.
    Marconi P; Argnani R; Epstein AL; Manservigi R
    Adv Exp Med Biol; 2009; 655():118-44. PubMed ID: 20047039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HSV as a vector in vaccine development and gene therapy.
    Marconi P; Argnani R; Berto E; Epstein AL; Manservigi R
    Hum Vaccin; 2008; 4(2):91-105. PubMed ID: 18496918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HSV-1-derived recombinant and amplicon vectors for gene transfer and gene therapy.
    Epstein AL; Marconi P; Argnani R; Manservigi R
    Curr Gene Ther; 2005 Oct; 5(5):445-58. PubMed ID: 16250886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Replication-competent herpes simplex vectors: design and applications.
    Argnani R; Lufino M; Manservigi M; Manservigi R
    Gene Ther; 2005 Oct; 12 Suppl 1():S170-7. PubMed ID: 16231051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene delivery using herpes simplex virus vectors.
    Burton EA; Fink DJ; Glorioso JC
    DNA Cell Biol; 2002 Dec; 21(12):915-36. PubMed ID: 12573050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical application of herpes simplex virus.
    Watanabe D
    J Dermatol Sci; 2010 Feb; 57(2):75-82. PubMed ID: 19939634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In situ cancer vaccination: an IL-12 defective vector/replication-competent herpes simplex virus combination induces local and systemic antitumor activity.
    Toda M; Martuza RL; Kojima H; Rabkin SD
    J Immunol; 1998 May; 160(9):4457-64. PubMed ID: 9574551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus-based vectors.
    Lachmann R
    Int J Exp Pathol; 2004 Oct; 85(4):177-90. PubMed ID: 15312123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HSV Recombinant Vectors for Gene Therapy.
    Manservigi R; Argnani R; Marconi P
    Open Virol J; 2010 Jun; 4():123-56. PubMed ID: 20835362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Friendly fire: redirecting herpes simplex virus-1 for therapeutic applications.
    Advani SJ; Weichselbaum RR; Whitley RJ; Roizman B
    Clin Microbiol Infect; 2002 Sep; 8(9):551-63. PubMed ID: 12427216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replication-Competent Controlled Herpes Simplex Virus.
    Bloom DC; Feller J; McAnany P; Vilaboa N; Voellmy R
    J Virol; 2015 Oct; 89(20):10668-79. PubMed ID: 26269179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus type 1 (HSV-1)-derived recombinant vectors for gene transfer and gene therapy.
    Marconi P; Fraefel C; Epstein AL
    Methods Mol Biol; 2015; 1254():269-93. PubMed ID: 25431072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a rapid method to generate multiple oncolytic HSV vectors and their in vivo evaluation using syngeneic mouse tumor models.
    Terada K; Wakimoto H; Tyminski E; Chiocca EA; Saeki Y
    Gene Ther; 2006 Apr; 13(8):705-14. PubMed ID: 16421599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of herpes simplex virus (HSV) vectors for gene therapy of neurological disorders.
    Kennedy PG
    Brain; 1997 Jul; 120 ( Pt 7)():1245-59. PubMed ID: 9236634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An efficient deletion mutant packaging system for defective herpes simplex virus vectors: potential applications to human gene therapy and neuronal physiology.
    Geller AI; Keyomarsi K; Bryan J; Pardee AB
    Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8950-4. PubMed ID: 2174168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene Transfer of Glutamic Acid Decarboxylase 67 by Herpes Simplex Virus Vectors Suppresses Neuropathic Pain Induced by Human Immunodeficiency Virus gp120 Combined with ddC in Rats.
    Kanao M; Kanda H; Huang W; Liu S; Yi H; Candiotti KA; Lubarsky DA; Levitt RC; Hao S
    Anesth Analg; 2015 Jun; 120(6):1394-404. PubMed ID: 25851180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of herpes simplex virus-based vectors for gene delivery to the nervous system.
    Lachmann RH; Efstathiou S
    Mol Med Today; 1997 Sep; 3(9):404-11. PubMed ID: 9302691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the development of herpes simplex virus-based gene transfer vectors for the nervous system.
    Fink DJ; Ramakrishnan R; Marconi P; Goins WF; Holland TC; Glorioso JC
    Clin Neurosci; 1995-1996; 3(5):284-91. PubMed ID: 8914795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetracycline-regulated gene expression in replication-incompetent herpes simplex virus vectors.
    Schmeisser F; Donohue M; Weir JP
    Hum Gene Ther; 2002 Dec; 13(18):2113-24. PubMed ID: 12542843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
    Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
    Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.